BR9406742A - Solução semelhante ao plasma - Google Patents

Solução semelhante ao plasma

Info

Publication number
BR9406742A
BR9406742A BR9406742A BR9406742A BR9406742A BR 9406742 A BR9406742 A BR 9406742A BR 9406742 A BR9406742 A BR 9406742A BR 9406742 A BR9406742 A BR 9406742A BR 9406742 A BR9406742 A BR 9406742A
Authority
BR
Brazil
Prior art keywords
solution
plasma
disclosed
dextran
administration
Prior art date
Application number
BR9406742A
Other languages
English (en)
Inventor
Paul E Segall
Hal Sternberg
Harold D Waitz
Judith M Segall
Original Assignee
Biotime Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26752331&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR9406742(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US08/071,533 external-priority patent/US5407428A/en
Application filed by Biotime Inc filed Critical Biotime Inc
Publication of BR9406742A publication Critical patent/BR9406742A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/10—Preservation of living parts
    • A01N1/12—Chemical aspects of preservation
    • A01N1/122—Preservation or perfusion media
    • A01N1/125—Freeze protecting agents, e.g. cryoprotectants or osmolarity regulators
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/10—Preservation of living parts
    • A01N1/16—Physical preservation processes
    • A01N1/162—Temperature processes, e.g. following predefined temperature changes over time
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/10—Carbonates; Bicarbonates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0026—Blood substitute; Oxygen transporting formulations; Plasma extender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Environmental Sciences (AREA)
  • Zoology (AREA)
  • Inorganic Chemistry (AREA)
  • Dentistry (AREA)
  • Hematology (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Physical Or Chemical Processes And Apparatus (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BR9406742A 1993-06-04 1994-06-03 Solução semelhante ao plasma BR9406742A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/071,533 US5407428A (en) 1993-06-04 1993-06-04 Solutions for use as plasma expanders and substitutes
US13352793A 1993-10-07 1993-10-07
PCT/US1994/006279 WO1994028950A1 (en) 1993-06-04 1994-06-03 Plasma-like solution

Publications (1)

Publication Number Publication Date
BR9406742A true BR9406742A (pt) 1996-03-12

Family

ID=26752331

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9406742A BR9406742A (pt) 1993-06-04 1994-06-03 Solução semelhante ao plasma

Country Status (16)

Country Link
US (14) US5702880A (pt)
EP (1) EP0701455B1 (pt)
JP (1) JP3715312B2 (pt)
KR (1) KR100267604B1 (pt)
CN (1) CN1102851C (pt)
AT (1) ATE199626T1 (pt)
AU (1) AU681675B2 (pt)
BR (1) BR9406742A (pt)
CA (1) CA2164321C (pt)
DE (1) DE69426879T2 (pt)
DK (1) DK0701455T3 (pt)
ES (1) ES2157260T3 (pt)
GR (1) GR3036013T3 (pt)
PT (1) PT701455E (pt)
RU (1) RU2142282C1 (pt)
WO (1) WO1994028950A1 (pt)

Families Citing this family (154)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6680305B1 (en) * 1993-06-04 2004-01-20 Biotime, Inc. Physiologically acceptable aqueous solutions and methods for their use
US6300322B1 (en) 1993-06-04 2001-10-09 Biotime, Inc. Plasma-like solution
US6627393B2 (en) * 1993-06-04 2003-09-30 Biotime, Inc. Solutions for use as plasma expanders and substitutes
US5945272A (en) * 1993-06-04 1999-08-31 Biotime, Incorporated Plasma expanders and blood substitutes
US5702880A (en) * 1993-06-04 1997-12-30 Biotime, Inc. Blood substitute comprising 0-5 mM K+
US6218099B1 (en) * 1994-06-03 2001-04-17 Biotime, Inc. Methods and compositions for use in perfusion applications
US6040132A (en) * 1996-06-14 2000-03-21 Biostore New Zealand, Ltd. Methods for the lyophilization of living biological materials
US5827640A (en) * 1996-06-14 1998-10-27 Biostore New Zealand Limited Methods for the preservation of cells and tissues using trimethylamine oxide or betaine with raffinose or trehalose
US6060233A (en) * 1996-06-14 2000-05-09 Biostore New Zealand, Ltd Methods for the lyophilization of platelets, platelet membranes or erythrocytes
US7166084B2 (en) * 1996-09-23 2007-01-23 Dsu Medical Corporation Blood set priming method and apparatus
US6387069B1 (en) * 1996-09-23 2002-05-14 Dsu Medical Corporation Blood set priming method and apparatus
US5804551A (en) * 1996-11-12 1998-09-08 Baxter International Inc. Pretraumatic use of hemoglobin
AU735799C (en) * 1997-02-28 2005-04-28 Regents Of The University Of California, The Methods and compositions for optimisation of oxygen transport by cell-free systems
US5814601A (en) * 1997-02-28 1998-09-29 The Regents Of The University Of California Methods and compositions for optimization of oxygen transport by cell-free systems
AU6865298A (en) * 1997-03-17 1998-10-12 Boris Rubinsky The use of cryoprotective agent compounds during cryosurgery
US5834178C1 (en) * 1997-07-09 2002-04-23 Univ Wayne State Flush-storage solution for donor organs
US8409846B2 (en) 1997-09-23 2013-04-02 The United States Of America As Represented By The Department Of Veteran Affairs Compositions, methods and devices for maintaining an organ
US6117166A (en) * 1997-10-27 2000-09-12 Winston; Thomas R. Apparatus and methods for grafting blood vessel tissue
SK6282000A3 (en) * 1997-10-31 2001-02-12 Biotime Inc Physiologically acceptable aqueous solutions and methods for their use
CN1068778C (zh) * 1998-05-15 2001-07-25 赵超英 救治用的药物组合物及其制备方法
EP1133244A4 (en) * 1998-11-25 2002-04-17 William F Aftoora LIQUID, WATER-SOLUBLE, ACIDITY-REDUCING FORMULA FOR FOOD AND BEVERAGES
US6706309B1 (en) 1998-11-25 2004-03-16 William F. Aftoora Liquefied water soluble acidity-reducing formulation for food and beverage products
US6589223B1 (en) * 1999-02-03 2003-07-08 Biotime, Inc. Method and compositions for use in perfusion applications
US6755811B1 (en) * 1999-08-25 2004-06-29 Corazon Technologies, Inc. Methods and devices for reducing the mineral content of a region of non-intimal vascular tissue
US6846842B2 (en) 1999-10-07 2005-01-25 Beth Israel Deconess Medical Center, Inc. Pyruvate ester composition and method of use for resuscitation after events of ischemia and reperfusion
US6759230B1 (en) * 1999-10-26 2004-07-06 The Board Of Regents, The University Of Texas Microbe, microbial exopolysaccharide, and uses thereof
US6492103B1 (en) * 2000-01-31 2002-12-10 Organ Recovery Systems, Inc. System for organ and tissue preservation and hypothermic blood substitution
US20060269575A1 (en) * 2000-02-08 2006-11-30 Allergan, Inc. Botulinum toxin pharmaceutical compositions formulated with recombinant albumin
US7780967B2 (en) * 2000-02-08 2010-08-24 Allergan, Inc. Reduced toxicity Clostridial toxin pharmaceutical compositions
US8632785B2 (en) * 2000-02-08 2014-01-21 Allergan, Inc. Clostridial toxin pharmaceutical composition containing a gelatin fragment
US20030118598A1 (en) * 2000-02-08 2003-06-26 Allergan, Inc. Clostridial toxin pharmaceutical compositions
ATE519494T1 (de) * 2000-02-08 2011-08-15 Allergan Inc Pharmazeutische zusammensetzungen mit botulinum- toxin
AU2001255339A1 (en) * 2000-04-14 2001-10-30 Biotime, Inc. Systems, kits, and methods of administering synthetic plasma
EP1305040B1 (en) * 2000-07-28 2009-09-09 Christopher J. Murphy Transplant media
RU2185173C2 (ru) * 2000-09-20 2002-07-20 Государственный институт кровезаменителей и медицинских препаратов Препарат гемодинамического действия с функцией нормализации кислотно-основного равновесия и электролитного баланса
AU2002214443B2 (en) 2000-11-03 2005-12-15 Vitrolife Ab Evaluation and preservation solution
US6746836B1 (en) 2000-12-08 2004-06-08 Abe Widra Alpha-keratose as a blood plasma expander and use thereof
US6864231B2 (en) * 2001-01-09 2005-03-08 Pharmachem Laboratories, Inc. Glycoprotein matrix compositions and methods related thereto
US6806069B2 (en) * 2001-01-09 2004-10-19 Pharmachem Laboratories, Inc. Ubiquinone composition and methods related thereto
EP1377339A4 (en) * 2001-04-04 2006-05-31 Critical Therapeutics Inc PROCEDURE FOR PREVENTING AKUTER NIERENINSUFFIZIENZ
US20050053912A1 (en) * 2001-06-11 2005-03-10 Roth Mark B. Methods for inducing reversible stasis
US20070213793A1 (en) * 2001-08-06 2007-09-13 Radiant Medical, Inc. Use of endovascular hypothermia in organ and/or tissue transplantations
AU2002336650B2 (en) 2001-10-25 2008-06-05 Emory University Catheter for modified perfusion
US20070160645A1 (en) * 2001-10-25 2007-07-12 Jakob Vinten-Johansen PostConditioning System And Method For The Reduction Of Ischemic-Reperfusion Injury In The Heart And Other Organs
US20050164915A1 (en) 2002-04-01 2005-07-28 Sangart, Inc. Compositions for oxygen transport comprising a high oxygen affinity modified hemoglobin
US20030153491A1 (en) * 2002-01-11 2003-08-14 Winslow Robert M. Methods and compositions for oxygen transport comprising a high oxygen affinity modified hemoglobin
CA2481753A1 (en) * 2002-04-17 2003-10-30 Critical Therapeutics, Inc. Method for treating ileus with an alpha -ketoalkanoic acid or - ester or - amide
JP3912206B2 (ja) * 2002-07-05 2007-05-09 株式会社日立製作所 筒内直接燃料噴射装置用燃料ポンプ
US20070029259A1 (en) * 2003-02-04 2007-02-08 Hirotaka Kakita Method of reducing impurity content in aqueous salt solution
EA010948B1 (ru) * 2003-05-01 2008-12-30 Инноджен Калбиотех Пте Лтд. Фармацевтическая композиция, содержащая лактат, и ее применение
DE502005001896D1 (en) * 2004-03-01 2007-12-20 Braun Melsungen Ag Hydroxyethylstärke
GB0407583D0 (en) * 2004-04-05 2004-05-05 Arbab Tarig S M Diagnostic testing and related matters
RU2273483C2 (ru) * 2004-05-06 2006-04-10 Санкт-Петербургский государственный университет Водорастворимый полимерный антиоксидант, плазмозаменитель с антиокислительной и антирадикальной активностью (варианты) и способ поддержания уровня артериального давления и процессов антиоксидантной защиты в организме при острой кровопотере
US7439012B2 (en) 2004-08-17 2008-10-21 Wake Forest University Health Sciences Ambient stored blood plasma expanders containing keratose
RU2262340C1 (ru) * 2004-09-14 2005-10-20 Панов Валерий Петрович Способ получения инфузионного препарата для экстренного восстановления и поддержания микроциркуляции крови
US12010987B2 (en) 2004-10-07 2024-06-18 Transmedics, Inc. Systems and methods for ex-vivo organ care and for using lactate as an indication of donor organ status
US9301519B2 (en) 2004-10-07 2016-04-05 Transmedics, Inc. Systems and methods for ex-vivo organ care
US8304181B2 (en) 2004-10-07 2012-11-06 Transmedics, Inc. Method for ex-vivo organ care and for using lactate as an indication of donor organ status
IL273422B (en) 2004-10-07 2022-07-01 Transmedics Inc Methods and systems for extracorporeal organ treatment
JP2008525468A (ja) * 2004-12-22 2008-07-17 エモリー・ユニバーシティ ポストコンディショニング臓器保護作用を増強する治療補助薬
JP2008538752A (ja) * 2005-04-12 2008-11-06 クレオ コスメティック アンド ファーマスーティカルカンパニー エルエルシー 角膜組織を生体外保存するための組成物および方法
PT1879599E (pt) * 2005-04-20 2014-01-23 Hutchinson Fred Cancer Res Métodos, composições e artigos de fabrico para aumentar a capacidade de sobrevivência de células, tecidos, órgãos, e organismos
US9078428B2 (en) 2005-06-28 2015-07-14 Transmedics, Inc. Systems, methods, compositions and solutions for perfusing an organ
CN101355953B (zh) * 2005-11-08 2014-07-09 味之素株式会社 麻醉苏醒促进剂
US7854754B2 (en) 2006-02-22 2010-12-21 Zeltiq Aesthetics, Inc. Cooling device for removing heat from subcutaneous lipid-rich cells
AU2006341414A1 (en) * 2006-04-03 2007-10-11 Innogene Kalbiotech Pte Ltd Lactate and calcium containing pharmaceutical composition and uses thereof
CA2980782C (en) 2006-04-19 2020-10-27 Transmedics, Inc. Systems and methods for ex vivo organ care
JP4703724B2 (ja) 2006-04-28 2011-06-15 ゼルティック エステティックス インコーポレイテッド 皮下の脂質リッチ細胞の冷却が改善された治療装置に使用する凍結防止剤
RU2315299C1 (ru) * 2006-09-20 2008-01-20 Государственное научное учреждение Всероссийский научно-исследовательский институт пищевой биотехнологии Российской академии сельскохозяйственных наук Рабочий электролит для определения капиллярным электрофорезом ионного состава жидких сред
US9132031B2 (en) 2006-09-26 2015-09-15 Zeltiq Aesthetics, Inc. Cooling device having a plurality of controllable cooling elements to provide a predetermined cooling profile
US20080077201A1 (en) 2006-09-26 2008-03-27 Juniper Medical, Inc. Cooling devices with flexible sensors
US8192474B2 (en) 2006-09-26 2012-06-05 Zeltiq Aesthetics, Inc. Tissue treatment methods
US9457179B2 (en) 2007-03-20 2016-10-04 Transmedics, Inc. Systems for monitoring and applying electrical currents in an organ perfusion system
US20080287839A1 (en) 2007-05-18 2008-11-20 Juniper Medical, Inc. Method of enhanced removal of heat from subcutaneous lipid-rich cells and treatment apparatus having an actuator
GB0712833D0 (en) * 2007-07-03 2007-08-08 Aqix Ltd Body Fluid Expander
US8523927B2 (en) 2007-07-13 2013-09-03 Zeltiq Aesthetics, Inc. System for treating lipid-rich regions
EP3488833B1 (en) 2007-08-21 2025-10-22 Zeltiq Aesthetics, Inc. Monitoring the cooling of subcutaneous lipid-rich cells, such as the cooling of adipose tissue
US20090123436A1 (en) * 2007-11-08 2009-05-14 Surmodics, Inc. Cryopreservative compositions and methods
US9814230B2 (en) 2008-01-31 2017-11-14 Transmedics, Inc. Systems and methods for ex vivo lung care
US20090263780A1 (en) * 2008-04-17 2009-10-22 Yanming Wang Organ preservation fluid
US8275442B2 (en) 2008-09-25 2012-09-25 Zeltiq Aesthetics, Inc. Treatment planning systems and methods for body contouring applications
US8603073B2 (en) 2008-12-17 2013-12-10 Zeltiq Aesthetics, Inc. Systems and methods with interrupt/resume capabilities for treating subcutaneous lipid-rich cells
CN101444526B (zh) * 2008-12-30 2012-06-27 杭州民生药业有限公司 一种药物组合物
CA2760610C (en) 2009-04-30 2017-09-19 Zeltiq Aesthetics, Inc. Device, system and method of removing heat from subcutaneous lipid-rich cells
SE534527C2 (sv) * 2009-09-24 2011-09-20 Vivoline Medical Ab Förfarande, anordning och vätska för behandling av ett hjärta efter uttagning
DE102009045589A1 (de) * 2009-10-12 2011-04-14 Universitätsklinikum Freiburg Vorrichtung zur Behandlung eines Individuums mit Herzminderleistung, Herzstillstand oder Schlaganfall
JP2013517897A (ja) 2010-01-25 2013-05-20 ゼルティック エステティックス インコーポレイテッド 熱を皮下多脂質細胞から相変化冷却剤を介して非侵襲的に除去するための家庭用アプリケータ及びそれと関連した装置、システム及び方法
WO2011160012A1 (en) * 2010-06-17 2011-12-22 The Trustees Of Columbia University In The City Of New York Tissue culture media containing trimethylamine n-oxide
US8676338B2 (en) 2010-07-20 2014-03-18 Zeltiq Aesthetics, Inc. Combined modality treatment systems, methods and apparatus for body contouring applications
IT1401386B1 (it) * 2010-07-30 2013-07-18 Eurotech S P A Dispositivo di raffreddamento a liquido per schede elettroniche, in particolare per unita' di elaborazione ad elevate prestazioni
GB201020300D0 (en) 2010-11-30 2011-01-12 Vitrolife Sweden Ab Product
US10722395B2 (en) 2011-01-25 2020-07-28 Zeltiq Aesthetics, Inc. Devices, application systems and methods with localized heat flux zones for removing heat from subcutaneous lipid-rich cells
US12096765B1 (en) 2011-03-15 2024-09-24 Paragonix Technologies, Inc. System for hypothermic transport of samples
US9426979B2 (en) 2011-03-15 2016-08-30 Paragonix Technologies, Inc. Apparatus for oxygenation and perfusion of tissue for organ preservation
US12279610B2 (en) 2011-03-15 2025-04-22 Paragonix Technonogies, Inc. System for hypothermic transport of samples
US9867368B2 (en) 2011-03-15 2018-01-16 Paragonix Technologies, Inc. System for hypothermic transport of samples
US9253976B2 (en) 2011-03-15 2016-02-09 Paragonix Technologies, Inc. Methods and devices for preserving tissues
US11178866B2 (en) 2011-03-15 2021-11-23 Paragonix Technologies, Inc. System for hypothermic transport of samples
EP2685814B1 (en) 2011-03-15 2016-08-17 Paragonix Technologies, Inc. Apparatus for oxygenation and perfusion of tissue for organ preservation
US8828710B2 (en) 2011-03-15 2014-09-09 Paragonix Technologies, Inc. System for hypothermic transport of samples
WO2012142487A1 (en) 2011-04-14 2012-10-18 Transmedics, Inc. Organ care solution for ex-vivo machine perfusion of donor lungs
CN102488942B (zh) * 2011-11-22 2013-03-20 安徽双鹤药业有限责任公司 回血试验方法及其回血试验装置
US20130330706A1 (en) * 2012-06-06 2013-12-12 Evan C. Unger Fluid for Suspended Animation
US9560846B2 (en) 2012-08-10 2017-02-07 Paragonix Technologies, Inc. System for hypothermic transport of biological samples
US8785116B2 (en) 2012-08-10 2014-07-22 Paragonix Technologies, Inc. Methods for evaluating the suitability of an organ for transplant
US9844460B2 (en) 2013-03-14 2017-12-19 Zeltiq Aesthetics, Inc. Treatment systems with fluid mixing systems and fluid-cooled applicators and methods of using the same
US9545523B2 (en) 2013-03-14 2017-01-17 Zeltiq Aesthetics, Inc. Multi-modality treatment systems, methods and apparatus for altering subcutaneous lipid-rich tissue
WO2015117036A2 (en) 2014-01-30 2015-08-06 Zeltiq Aesthetics, Inc. Treatment systems, methods, and apparatuses for improving the appearance of skin and providing for other treatments
US10675176B1 (en) 2014-03-19 2020-06-09 Zeltiq Aesthetics, Inc. Treatment systems, devices, and methods for cooling targeted tissue
USD777338S1 (en) 2014-03-20 2017-01-24 Zeltiq Aesthetics, Inc. Cryotherapy applicator for cooling tissue
US10952891B1 (en) 2014-05-13 2021-03-23 Zeltiq Aesthetics, Inc. Treatment systems with adjustable gap applicators and methods for cooling tissue
CA3185937A1 (en) 2014-06-02 2015-12-10 Transmedics, Inc. Ex vivo organ care system
US10935174B2 (en) 2014-08-19 2021-03-02 Zeltiq Aesthetics, Inc. Stress relief couplings for cryotherapy apparatuses
US10568759B2 (en) 2014-08-19 2020-02-25 Zeltiq Aesthetics, Inc. Treatment systems, small volume applicators, and methods for treating submental tissue
AU2015361996B2 (en) 2014-12-12 2019-09-26 Transmedics, Inc. Apparatus and method for organ perfusion
JP2018516965A (ja) * 2015-06-10 2018-06-28 セルフィアー インコーポレイテッド 低血圧（ｈｙｐｏｔｅｎｓｉｏｎ）および／または血液量減少（ｈｙｐｏｖｏｌｅｍｉａ）に至る体液（ｆｌｕｉｄｓ）の喪失の治療のための組成物および方法
SG10201913250SA (en) 2015-08-18 2020-03-30 Astellas Inst For Regenerative Medicine Clinical formulations
DK3824731T3 (da) 2015-09-09 2025-05-26 Transmedics Inc Aortakanyle til ex vivo-organplejesystem
US10448631B2 (en) 2015-09-22 2019-10-22 East Carolina University Cryopreservation using sucralose
WO2017070112A1 (en) 2015-10-19 2017-04-27 Zeltiq Aesthetics, Inc. Vascular treatment systems, cooling devices, and methods for cooling vascular structures
CA3009414A1 (en) 2016-01-07 2017-07-13 Zeltiq Aesthetics, Inc. Temperature-dependent adhesion between applicator and skin during cooling of tissue
US10765552B2 (en) 2016-02-18 2020-09-08 Zeltiq Aesthetics, Inc. Cooling cup applicators with contoured heads and liner assemblies
CN106092848B (zh) * 2016-03-22 2018-07-06 威海威高血液净化制品有限公司 透析器超滤性能测试液
US11382790B2 (en) 2016-05-10 2022-07-12 Zeltiq Aesthetics, Inc. Skin freezing systems for treating acne and skin conditions
US10682297B2 (en) 2016-05-10 2020-06-16 Zeltiq Aesthetics, Inc. Liposomes, emulsions, and methods for cryotherapy
US10555831B2 (en) 2016-05-10 2020-02-11 Zeltiq Aesthetics, Inc. Hydrogel substances and methods of cryotherapy
EP4238417A3 (en) 2016-05-30 2023-12-06 Tevosol, Inc. Apparatus and method for ex vivo lung ventilation with a varying exterior pressure
US10456423B2 (en) 2016-06-13 2019-10-29 SMART SURGICAL, Inc. Compositions for biological systems and methods for preparing and using the same
US10426796B2 (en) 2016-06-13 2019-10-01 SMART SURGICAL, Inc. Compositions for biological systems and methods for preparing and using the same
ES2651717B1 (es) * 2016-07-26 2018-11-16 Lara OLLER DUQUE Solución acuosa cristaloide isotónica
AU2016431615A1 (en) * 2016-12-08 2019-06-20 Cellphire, Inc. Compositions and methods for treatment of loss of fluids leading to hypotension and/or hypovolemia
US11076879B2 (en) 2017-04-26 2021-08-03 Zeltiq Aesthetics, Inc. Shallow surface cryotherapy applicators and related technology
US20210400952A1 (en) 2017-06-07 2021-12-30 Paragonix Technologies, Inc. Apparatus for tissue transport and preservation
WO2018226993A1 (en) 2017-06-07 2018-12-13 Paragonix Technologies, Inc. Apparatus for tissue transport and preservation
CA3107932A1 (en) 2018-07-31 2020-02-06 Zeltiq Aesthetics, Inc. Methods, devices, and systems for improving skin characteristics
EP3887404A4 (en) 2018-11-30 2022-11-02 Cellphire, Inc. SLIDES LOADED WITH ANTI-CANCER AGENTS
US11767511B2 (en) 2018-11-30 2023-09-26 Cellphire, Inc. Platelets as delivery agents
EP3893862B1 (en) 2018-12-14 2023-11-22 National Taiwan University A stable cardioplegic solution for cardiac surgery
AU2020267368B2 (en) 2019-05-03 2023-05-04 Cellphire, Inc. Materials and methods for producing blood products
MX2021014874A (es) 2019-06-03 2022-03-25 Cooler Heads Care Inc Conjunto de gorro de enfriamiento y unidad de enfriamiento.
EP3982725A4 (en) 2019-06-11 2023-07-19 Paragonix Technologies Inc. ORGAN TRANSPORT CONTAINER WITH ANTIVIRAL THERAPY
EP4013496A4 (en) 2019-08-16 2023-10-18 Cellphire Inc. THROMBOSOMES AS AN AGENT FOR REMOVING THE THROMBOCYTE AGGREGATION-INHIBITING EFFECT
US11632951B2 (en) 2020-01-31 2023-04-25 Paragonix Technologies, Inc. Apparatus for tissue transport and preservation
CA3170201A1 (en) 2020-02-04 2021-08-12 Cellphire, Inc. Methods of treating congenital hemophilia with anti-fibrinolytic loaded platelets
US12161777B2 (en) 2020-07-02 2024-12-10 Davol Inc. Flowable hemostatic suspension
US11739166B2 (en) 2020-07-02 2023-08-29 Davol Inc. Reactive polysaccharide-based hemostatic agent
IT202000027050A1 (it) * 2020-11-12 2022-05-12 S A L F S P A Laboratorio Farm Soluzione colloidale per la perfusione e la conservazione ex-vivo dei polmoni
EP4267210A1 (en) 2020-12-28 2023-11-01 Davol Inc. Reactive dry powdered hemostatic materials comprising a protein and a multifunctionalized modified polyethylene glycol based crosslinking agent
TW202245814A (zh) 2021-02-17 2022-12-01 美商賽菲爾公司 用於治療抗血小板誘導的凝血病之凍乾血小板衍生物組成物
USD1031028S1 (en) 2022-09-08 2024-06-11 Paragonix Technologies, Inc. Tissue suspension adaptor
US12485064B2 (en) 2023-08-25 2025-12-02 Paragonix Technologies, Inc. Systems and methods for measuring oxygen concentration for lung preservation
US20250248390A1 (en) 2024-02-02 2025-08-07 Paragonix Technologies, Inc. System for perfusion of an organ
US12419850B1 (en) 2024-03-21 2025-09-23 GanD, Inc. Bioactive fluid compositions
USD1087382S1 (en) 2025-01-30 2025-08-05 Paragonix Technologies, Inc. Device for transporting a biological sample

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US34077A (en) * 1862-01-07 Improvement in weighing-registers
SU44311A1 (ru) * 1934-09-15 1935-09-30 В.Г. Гуревич Способ приготовлени искусственной кров ной сыворотки
US3356570A (en) * 1964-11-27 1967-12-05 Trustees Of Barnes Hospital Composition for treating shock
US3758382A (en) * 1968-07-26 1973-09-11 Us Navy Ve agent process of freezing blood using a hydroxyalkyl starch as cryoprotecti
ZA702706B (en) * 1969-04-28 1971-12-29 Knox Gelatine Inc Blood plasma substitute
US3897550A (en) * 1971-06-01 1975-07-29 Cybersol Method for administering water soluble drugs, nutrients and other solutes to a mammal
US3937821A (en) * 1971-08-21 1976-02-10 Kyorin Seiyaku Kabushiki Kaisha Plasma substitute including artificial starch and method for the preparation thereof
US3949098A (en) * 1974-06-05 1976-04-06 Nabisco, Inc. Nutritious orange drink concentrate, process and drink resultant therefrom
US4001401A (en) * 1975-02-02 1977-01-04 Alza Corporation Blood substitute and blood plasma expander comprising polyhemoglobin
US4061736A (en) * 1975-02-02 1977-12-06 Alza Corporation Pharmaceutically acceptable intramolecularly cross-linked, stromal-free hemoglobin
DE2801123C2 (de) * 1977-01-26 1986-01-02 Armour Pharma GmbH & Co KG, 3440 Eschwege Verfahren zur Herstellung eines intravenös applizierbaren Serumeiweiß-Präparates
US4609372A (en) * 1983-10-13 1986-09-02 Miles Laboratories, Inc. Heat sterilizable storage solution for red blood cells
EP0179879A1 (en) * 1984-04-27 1986-05-07 Synthetic Blood Corporation A substitute for human blood and a method of making the same
JPS61502943A (ja) * 1984-06-22 1986-12-18 ビ−チ、リチャ−ド・エル 電解質溶液およびその生体内における使用
US5084377A (en) * 1984-09-19 1992-01-28 Larry Rowan Cryogenic suspension method
US4879283A (en) * 1985-10-03 1989-11-07 Wisconsin Alumni Research Foundation Solution for the preservation of organs
US4908350A (en) * 1985-10-31 1990-03-13 The Regents Of The University Of California Hyperosmotic/hyperoncotic solutions for resuscitation of hypodynamic shock
US4769318A (en) * 1986-06-03 1988-09-06 Ube Industries, Ltd. Additive solution for blood preservation and activation
US5210083A (en) * 1986-07-17 1993-05-11 Ed. Geistlich Sohne A.G. Fur Chemische Industrie Pharmaceutical compositions
JPS6360931A (ja) * 1986-08-29 1988-03-17 Noboru Sato 血液または血液製剤保存液およびこれを用いた血液または血液製剤の保存方法
US4927806A (en) * 1987-04-23 1990-05-22 The Regents Of The University Of California Saturated salt/concentrated dextran formulation to treat hemorrhage
US5274001A (en) * 1987-12-24 1993-12-28 Borody Thomas J Orthostatic lavage solutions
US4988515A (en) * 1988-01-28 1991-01-29 The Regents Of The Univ. Of Calif. Cardioplegic solution
USRE34077E (en) * 1988-05-02 1992-09-22 Cryomedical Sciences, Inc. Blood substitute
US4923442A (en) * 1988-05-02 1990-05-08 Cryomedical Sciences Inc. Blood substitute
US5130230A (en) * 1988-05-02 1992-07-14 Cryomedical Sciences, Inc. Blood substitute
JPH03220201A (ja) * 1988-11-18 1991-09-27 Eisai Co Ltd プロスタグランジン類と多糖類の結合体
US5252213A (en) * 1989-06-20 1993-10-12 University Of Washington Dry dialysate composition
US5082831A (en) * 1989-12-05 1992-01-21 Cryovita Laboratories, Inc. Total body washout solution and method of use
US5171526A (en) * 1990-01-05 1992-12-15 Allergan, Inc. Ophthalmic compositions and methods for preserving and using same
US5416078A (en) * 1990-03-30 1995-05-16 Biomedical Frontiers, Inc. Fluid resuscitation
EP0523037A4 (en) * 1990-03-30 1993-07-28 Biomedical Frontiers, Inc. Fluid resuscitation
US5248766A (en) * 1990-08-17 1993-09-28 Baxter International Inc. Oxirane-modified hemoglobin based composition
GB9021325D0 (en) * 1990-10-01 1990-11-14 Geistlich Soehne Ag Chemical composition
EP0510185B1 (en) * 1990-11-07 1996-12-11 Baxter International Inc. Blood platelet storage medium
CA2066374C (en) * 1991-04-19 2002-01-29 Paul E. Segall Solution for perfusing primates
WO1993002653A1 (en) * 1991-08-08 1993-02-18 Segel Leigh D Fluorocarbon blood substitute
US5702880A (en) * 1993-06-04 1997-12-30 Biotime, Inc. Blood substitute comprising 0-5 mM K+
US5407428A (en) 1993-06-04 1995-04-18 Biotime, Inc. Solutions for use as plasma expanders and substitutes

Also Published As

Publication number Publication date
CA2164321A1 (en) 1994-12-22
DK0701455T3 (da) 2001-06-18
CN1102851C (zh) 2003-03-12
KR100267604B1 (ko) 2000-11-01
US5733894A (en) 1998-03-31
WO1994028950A1 (en) 1994-12-22
US5723281A (en) 1998-03-03
US6080538A (en) 2000-06-27
DE69426879T2 (de) 2001-10-18
EP0701455B1 (en) 2001-03-14
HK1010698A1 (en) 1999-06-25
US20020009783A1 (en) 2002-01-24
US20020012957A1 (en) 2002-01-31
RU2142282C1 (ru) 1999-12-10
US5613944A (en) 1997-03-25
JP3715312B2 (ja) 2005-11-09
US6387612B1 (en) 2002-05-14
US6406839B1 (en) 2002-06-18
US5968726A (en) 1999-10-19
EP0701455A4 (en) 1998-01-07
US5747071A (en) 1998-05-05
ES2157260T3 (es) 2001-08-16
ATE199626T1 (de) 2001-03-15
DE69426879D1 (de) 2001-04-19
US5698536A (en) 1997-12-16
US5702880A (en) 1997-12-30
AU7052594A (en) 1995-01-03
US6110504A (en) 2000-08-29
GR3036013T3 (en) 2001-09-28
US5571801A (en) 1996-11-05
AU681675B2 (en) 1997-09-04
US6444418B2 (en) 2002-09-03
CN1127476A (zh) 1996-07-24
US6410218B2 (en) 2002-06-25
EP0701455A1 (en) 1996-03-20
US20020025562A1 (en) 2002-02-28
JPH08511265A (ja) 1996-11-26
PT701455E (pt) 2001-09-27
CA2164321C (en) 2002-08-20

Similar Documents

Publication Publication Date Title
BR9406742A (pt) Solução semelhante ao plasma
KR890009409A (ko) 기관 보존 및 저장에 적당한 조성물 및 기관 보조 방법
US5145771A (en) Rinse solution for organs and tissues
US5552267A (en) Solution for prolonged organ preservation
CA2066374A1 (en) Solution for perfusing primates
JUDD et al. Cardiac transplantation in mice I. Factors influencing the take and survival of heterotopic grafts
ATE235813T1 (de) Verfahren zur vorbereitung von organen auf die kryokonservierung
Hällgren et al. Accumulation of hyaluronan (hyaluronic acid) in myocardial interstitial tissue parallels development of transplantation edema in heart allografts in rats.
KR100855354B1 (ko) 관류세척 보존 용액
PT852491E (pt) Utilizacao de heparinases para diminuir respostas inflamatorias
ATE249249T1 (de) Steriler komplex eines therapeutischen peptids an ein polysaccharid
Bermudez et al. Oxidative and non-oxidative intracellular killing of Mycobacterium avium complex
ZA200107243B (en) Methods and compositions for use in perfusion applications.
Haag-Weber et al. Impaired cellular host defence in peritoneal dialysis by two granulocyte inhibitory proteins
Weissmann et al. Studies of lysosomes—VIII: The effect of polyene antibiotics on lysosomes
US5556842A (en) Method for viable preservation of lung grafts
JPH0822801B2 (ja) 臓器保存用溶液
WO1989010746A3 (en) Blood substitute
US6313104B1 (en) Organoprotective solutions
Chang-Chun et al. Effect of a cyclic adenosine monophosphate phosphodiesterase inhibitor, DN-9693, on myocardial reperfusion injury
ITMI922950A1 (it) Oligosaccaridi aventi attivita' biologica e procedimento per la loro preparazione di glicosaminoglicani
CA2359482A1 (en) Organoprotective solutions
JPH11246301A (ja) 臓器保存溶液
EP0295826A1 (en) Method of using superoxide dismutase during surgical procedures
FUJINAMI et al. Fibrinolytic activity of the endothelium

Legal Events

Date Code Title Description
EG Technical examination (opinion): publication of technical examination (opinion)
FC Decision: refusal
CKFC Appeal: appeal against refusal